Reference : HBA1c: clinical and biological agreement for standardization of assay methode. Report...
Scientific journals : Article
Human health sciences : Laboratory medicine & medical technology
http://hdl.handle.net/2268/34248
HBA1c: clinical and biological agreement for standardization of assay methode. Report by the expert of ALFEDIAM (Association de Langue française pour l'étude du diabète et des maladies métaboliques) and SFBC (Société française de Biologie clinique)
English
Gillery, Pierre [ > > ]
Bordas-Fonfrède, M. [ > > ]
Chapelle, Jean-Paul mailto [Université de Liège - ULg > Département de pharmacie > Chimie médicale >]
Drouin, P. [ > > ]
Hue, G. [ > > ]
Levy-Marchal, C. [ > > ]
Périer, C. [ > > ]
Sélam, J. L. [ > > ]
Slama, G. [ > > ]
Thivolet, C. [ > > ]
Vialettes, B. [ > > ]
Sep-1999
Diabète & Métabolisme
Masson
25
3
283-7
Yes (verified by ORBi)
International
0338-1684
Paris
France
[en] Glycohaemoglobin, and particularly haemoglobin A1c(HbA1c), assays have been used for many years to retrospectively evaluate the glycaemic control of diabetic patients. Cut-off values have been established for deciding treatment modifications. The techniques used in the laboratories however exhibit varying quality, and all of them are not yet standardized. The consequence is an under-utilization of this test, especially in non-hospital practice. In this context, working groups of Société Française de Biologie Clinique (SFBC), Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques (ALFEDIAM) and Société Française d'Endocrinologie (SFE) have met together, in order to analyze the national status, and to propose practical recommendations for implementing a standardization process on the basis of international experiences. It is recommended to exclusively express results as HbA1c percentage, using methods standardized and certified by comparison to reference methods such as those using Diabetes Control and Complications Trial (DCCT) values. Simultaneously, contacts have been established with manufacturers, and the realisation of periodic quality control surveys was encouraged.
http://hdl.handle.net/2268/34248

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
HBA1c clinical and biological agrreemnt for standadization...full text.pdfPublisher postprint66.45 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.